NCT02212834

Brief Summary

The purpose of this study is to determine the effectiveness of surveillance breast MRI compared to mammography alone in women with a personal history of breast cancer

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36,444

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2013

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

March 21, 2014

Completed
5 months until next milestone

First Posted

Study publicly available on registry

August 8, 2014

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2016

Completed
3 months until next milestone

Results Posted

Study results publicly available

February 7, 2017

Completed
Last Updated

August 22, 2024

Status Verified

July 1, 2024

Enrollment Period

3.1 years

First QC Date

March 21, 2014

Results QC Date

November 28, 2016

Last Update Submit

July 26, 2024

Conditions

Keywords

BreastCancerSurveillanceImagingComparativeEffectiveness

Outcome Measures

Primary Outcomes (1)

  • Number of Breast Cancers Detected

    Number of second breast cancers detected in the 12 months after surveillance mammogram or breast MRI

    12 months post surveillance exam

Study Arms (2)

Mammograms

Surveillance mammograms in women with a personal history of breast cancer

Breast MRI

Surveillance breast Magnetic Resonance Imaging (MRI) in women with a personal history of breast cancer

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Surveillance imaging exams in women included in the Breast Cancer Surveillance Consortium who are 18+ years of age at the the of a Stage 0-III incident breast cancer diagnosis between January 1, 2005 and December 31, 2012.

You may not qualify if:

  • Women with a diagnosis of lobular carcinoma in situ
  • Women with missing cancer staging data from Surveillance, Epidemiology and End Results (SEER) Program records
  • Women with Stage 4 breast cancer at time of diagnosis
  • Women with a diagnosis of a second breast cancer event within six months of the primary diagnosis
  • Women who die within six months of primary diagnosis
  • Women who have had a double mastectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Johnson DS, Bush MT, Brandzel S, Wernli KJ. The patient voice in research-evolution of a role. Res Involv Engagem. 2016 Feb 22;2:6. doi: 10.1186/s40900-016-0020-4. eCollection 2016.

    PMID: 29062507BACKGROUND
  • Henderson LM, Ichikawa L, Buist DSM, Lee JM, Bush M, Johnson D, Onega T, Nekhlyudov L, Kerlikowske K, Miglioretti DL, Sprague BL, Wernli KJ. Patterns of Breast Imaging Use Among Women with a Personal History of Breast Cancer. J Gen Intern Med. 2019 Oct;34(10):2098-2106. doi: 10.1007/s11606-019-05181-6. Epub 2019 Aug 13.

    PMID: 31410813BACKGROUND
  • Wernli KJ, Ichikawa L, Kerlikowske K, Buist DSM, Brandzel SD, Bush M, Johnson D, Henderson LM, Nekhlyudov L, Onega T, Sprague BL, Lee JM, Lehman CD, Miglioretti DL. Surveillance Breast MRI and Mammography: Comparison in Women with a Personal History of Breast Cancer. Radiology. 2019 Aug;292(2):311-318. doi: 10.1148/radiol.2019182475. Epub 2019 Jun 4.

Related Links

MeSH Terms

Conditions

Breast NeoplasmsNeoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Limitations and Caveats

This study was not a clinical trial. It was a cohort analysis of existing data.

Results Point of Contact

Title
Karen J. Wernli, PhD
Organization
Group Health Research Institute

Study Officials

  • Karen J. Wernli, PhD

    Group Health Research Institute

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2014

First Posted

August 8, 2014

Study Start

October 1, 2013

Primary Completion

November 1, 2016

Study Completion

November 1, 2016

Last Updated

August 22, 2024

Results First Posted

February 7, 2017

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share